CHANGES OF HEMOSTATIC MOLECULAR MARKERS DURING DONOR PLATELETPHERESES USING CELL SEPARATORS
The changes of hemostatic molecular markers such as beta-thromboglobulin, platelet factor 4, fibrinopeptide A, soluble fibrin monomer complex, fibrinopeptide B beta 15-42, fibrin degradation product and fibrinogen are measured during donor plateltphereses using cell separators. They are most sensiti...
Gespeichert in:
| Veröffentlicht in: | Journal of the Japan Society of Blood Transfusion 1987, Vol.33(5), pp.485-491 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | jpn |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 491 |
|---|---|
| container_issue | 5 |
| container_start_page | 485 |
| container_title | Journal of the Japan Society of Blood Transfusion |
| container_volume | 33 |
| creator | Teruya, Jun Umejima, Akemi Tsuruoka, Yumiko Kazama, Mutsuyoshi Morioka, Machiko Sugiyama, Miyuki Kamakura, Masahide Abe, Takeshi |
| description | The changes of hemostatic molecular markers such as beta-thromboglobulin, platelet factor 4, fibrinopeptide A, soluble fibrin monomer complex, fibrinopeptide B beta 15-42, fibrin degradation product and fibrinogen are measured during donor plateltphereses using cell separators. They are most sensitive markers of platelet, coagulation system, and fibrinolysis. Plateletphereses were performed using Phenwall CS3000 in 13 cases and IBM2997 in 8 cases. Platelet and coagulation system were activated during plateletpheresis, although any side effect was not recognized. From the results we perform that processed volume of whole blood should be limited 2, 000ml, approximately half of ordinary apheresis, in cases of donors from the age of 45 to 54. In addition donors who are considered to have any risk factor for thrombosis also should be omitted for plateletpheresis. |
| doi_str_mv | 10.3925/jjtc1958.33.485 |
| format | Article |
| fullrecord | <record><control><sourceid>jstage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3925_jjtc1958_33_485</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>article_jjtc1958_33_5_33_5_485_article_char_en</sourcerecordid><originalsourceid>FETCH-LOGICAL-c158n-509af2dcbcbce186a9aa8f80e46a9db2797bcb0c5fce5300777595bfb93ffced3</originalsourceid><addsrcrecordid>eNpVkFFrwjAQx8PYYOJ83mu-QDUxjU0fQ422LFpJ2qc9hDSmm8W50fqyb7-ImzAO7o773-84_gA8YzQl6ZzOuu7scErZlJBpzOgdGGHGSMQII_dghGi8iHAcs0cwGYYOIYQZZgsaj8BrlvPtWmhYrmAuNqWueFVkcFNKkdWSK7jh6kUoDZe1KrZruCy3pYI7ySshRbXLhRI60LW-iJmQEmqx44pXpdJP4KG1x8FPfusY1CtRZXkky3WRcRk5TNkpoii17XzvmhA-vGVTa1nLkI9Du2_mSZoECTnaOk8JQkmS0JQ2bZOSNoz2ZAxm17uu_xyG3rfmqz982P7bYGQu9pg_ewwhJtgTiOWV6IazffO3fdufD-7o_-3TawrYTXbvtjf-RH4AS8hrGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CHANGES OF HEMOSTATIC MOLECULAR MARKERS DURING DONOR PLATELETPHERESES USING CELL SEPARATORS</title><source>J-STAGE Free</source><creator>Teruya, Jun ; Umejima, Akemi ; Tsuruoka, Yumiko ; Kazama, Mutsuyoshi ; Morioka, Machiko ; Sugiyama, Miyuki ; Kamakura, Masahide ; Abe, Takeshi</creator><creatorcontrib>Teruya, Jun ; Umejima, Akemi ; Tsuruoka, Yumiko ; Kazama, Mutsuyoshi ; Morioka, Machiko ; Sugiyama, Miyuki ; Kamakura, Masahide ; Abe, Takeshi</creatorcontrib><description>The changes of hemostatic molecular markers such as beta-thromboglobulin, platelet factor 4, fibrinopeptide A, soluble fibrin monomer complex, fibrinopeptide B beta 15-42, fibrin degradation product and fibrinogen are measured during donor plateltphereses using cell separators. They are most sensitive markers of platelet, coagulation system, and fibrinolysis. Plateletphereses were performed using Phenwall CS3000 in 13 cases and IBM2997 in 8 cases. Platelet and coagulation system were activated during plateletpheresis, although any side effect was not recognized. From the results we perform that processed volume of whole blood should be limited 2, 000ml, approximately half of ordinary apheresis, in cases of donors from the age of 45 to 54. In addition donors who are considered to have any risk factor for thrombosis also should be omitted for plateletpheresis.</description><identifier>ISSN: 0546-1448</identifier><identifier>EISSN: 1883-8383</identifier><identifier>DOI: 10.3925/jjtc1958.33.485</identifier><language>jpn</language><publisher>The Japan Society of Transfusion Medicine and Cell Therapy</publisher><ispartof>Journal of the Japan Society of Blood Transfusion, 1987, Vol.33(5), pp.485-491</ispartof><rights>The Japan Society of Transfusion Medicine and Cell Therapy</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27900,27901,27902</link.rule.ids></links><search><creatorcontrib>Teruya, Jun</creatorcontrib><creatorcontrib>Umejima, Akemi</creatorcontrib><creatorcontrib>Tsuruoka, Yumiko</creatorcontrib><creatorcontrib>Kazama, Mutsuyoshi</creatorcontrib><creatorcontrib>Morioka, Machiko</creatorcontrib><creatorcontrib>Sugiyama, Miyuki</creatorcontrib><creatorcontrib>Kamakura, Masahide</creatorcontrib><creatorcontrib>Abe, Takeshi</creatorcontrib><title>CHANGES OF HEMOSTATIC MOLECULAR MARKERS DURING DONOR PLATELETPHERESES USING CELL SEPARATORS</title><title>Journal of the Japan Society of Blood Transfusion</title><addtitle>J. j. t. m</addtitle><description>The changes of hemostatic molecular markers such as beta-thromboglobulin, platelet factor 4, fibrinopeptide A, soluble fibrin monomer complex, fibrinopeptide B beta 15-42, fibrin degradation product and fibrinogen are measured during donor plateltphereses using cell separators. They are most sensitive markers of platelet, coagulation system, and fibrinolysis. Plateletphereses were performed using Phenwall CS3000 in 13 cases and IBM2997 in 8 cases. Platelet and coagulation system were activated during plateletpheresis, although any side effect was not recognized. From the results we perform that processed volume of whole blood should be limited 2, 000ml, approximately half of ordinary apheresis, in cases of donors from the age of 45 to 54. In addition donors who are considered to have any risk factor for thrombosis also should be omitted for plateletpheresis.</description><issn>0546-1448</issn><issn>1883-8383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><recordid>eNpVkFFrwjAQx8PYYOJ83mu-QDUxjU0fQ422LFpJ2qc9hDSmm8W50fqyb7-ImzAO7o773-84_gA8YzQl6ZzOuu7scErZlJBpzOgdGGHGSMQII_dghGi8iHAcs0cwGYYOIYQZZgsaj8BrlvPtWmhYrmAuNqWueFVkcFNKkdWSK7jh6kUoDZe1KrZruCy3pYI7ySshRbXLhRI60LW-iJmQEmqx44pXpdJP4KG1x8FPfusY1CtRZXkky3WRcRk5TNkpoii17XzvmhA-vGVTa1nLkI9Du2_mSZoECTnaOk8JQkmS0JQ2bZOSNoz2ZAxm17uu_xyG3rfmqz982P7bYGQu9pg_ewwhJtgTiOWV6IazffO3fdufD-7o_-3TawrYTXbvtjf-RH4AS8hrGw</recordid><startdate>1987</startdate><enddate>1987</enddate><creator>Teruya, Jun</creator><creator>Umejima, Akemi</creator><creator>Tsuruoka, Yumiko</creator><creator>Kazama, Mutsuyoshi</creator><creator>Morioka, Machiko</creator><creator>Sugiyama, Miyuki</creator><creator>Kamakura, Masahide</creator><creator>Abe, Takeshi</creator><general>The Japan Society of Transfusion Medicine and Cell Therapy</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1987</creationdate><title>CHANGES OF HEMOSTATIC MOLECULAR MARKERS DURING DONOR PLATELETPHERESES USING CELL SEPARATORS</title><author>Teruya, Jun ; Umejima, Akemi ; Tsuruoka, Yumiko ; Kazama, Mutsuyoshi ; Morioka, Machiko ; Sugiyama, Miyuki ; Kamakura, Masahide ; Abe, Takeshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c158n-509af2dcbcbce186a9aa8f80e46a9db2797bcb0c5fce5300777595bfb93ffced3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1987</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Teruya, Jun</creatorcontrib><creatorcontrib>Umejima, Akemi</creatorcontrib><creatorcontrib>Tsuruoka, Yumiko</creatorcontrib><creatorcontrib>Kazama, Mutsuyoshi</creatorcontrib><creatorcontrib>Morioka, Machiko</creatorcontrib><creatorcontrib>Sugiyama, Miyuki</creatorcontrib><creatorcontrib>Kamakura, Masahide</creatorcontrib><creatorcontrib>Abe, Takeshi</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of the Japan Society of Blood Transfusion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teruya, Jun</au><au>Umejima, Akemi</au><au>Tsuruoka, Yumiko</au><au>Kazama, Mutsuyoshi</au><au>Morioka, Machiko</au><au>Sugiyama, Miyuki</au><au>Kamakura, Masahide</au><au>Abe, Takeshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CHANGES OF HEMOSTATIC MOLECULAR MARKERS DURING DONOR PLATELETPHERESES USING CELL SEPARATORS</atitle><jtitle>Journal of the Japan Society of Blood Transfusion</jtitle><addtitle>J. j. t. m</addtitle><date>1987</date><risdate>1987</risdate><volume>33</volume><issue>5</issue><spage>485</spage><epage>491</epage><pages>485-491</pages><issn>0546-1448</issn><eissn>1883-8383</eissn><abstract>The changes of hemostatic molecular markers such as beta-thromboglobulin, platelet factor 4, fibrinopeptide A, soluble fibrin monomer complex, fibrinopeptide B beta 15-42, fibrin degradation product and fibrinogen are measured during donor plateltphereses using cell separators. They are most sensitive markers of platelet, coagulation system, and fibrinolysis. Plateletphereses were performed using Phenwall CS3000 in 13 cases and IBM2997 in 8 cases. Platelet and coagulation system were activated during plateletpheresis, although any side effect was not recognized. From the results we perform that processed volume of whole blood should be limited 2, 000ml, approximately half of ordinary apheresis, in cases of donors from the age of 45 to 54. In addition donors who are considered to have any risk factor for thrombosis also should be omitted for plateletpheresis.</abstract><pub>The Japan Society of Transfusion Medicine and Cell Therapy</pub><doi>10.3925/jjtc1958.33.485</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0546-1448 |
| ispartof | Journal of the Japan Society of Blood Transfusion, 1987, Vol.33(5), pp.485-491 |
| issn | 0546-1448 1883-8383 |
| language | jpn |
| recordid | cdi_crossref_primary_10_3925_jjtc1958_33_485 |
| source | J-STAGE Free |
| title | CHANGES OF HEMOSTATIC MOLECULAR MARKERS DURING DONOR PLATELETPHERESES USING CELL SEPARATORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T21%3A05%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CHANGES%20OF%20HEMOSTATIC%20MOLECULAR%20MARKERS%20DURING%20DONOR%20PLATELETPHERESES%20USING%20CELL%20SEPARATORS&rft.jtitle=Journal%20of%20the%20Japan%20Society%20of%20Blood%20Transfusion&rft.au=Teruya,%20Jun&rft.date=1987&rft.volume=33&rft.issue=5&rft.spage=485&rft.epage=491&rft.pages=485-491&rft.issn=0546-1448&rft.eissn=1883-8383&rft_id=info:doi/10.3925/jjtc1958.33.485&rft_dat=%3Cjstage_cross%3Earticle_jjtc1958_33_5_33_5_485_article_char_en%3C/jstage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |